HCC Risk Prediction Model - For Treatment-Naive Patients

1. Model for Treatment-Naive Patients 2. Model for Patients Under Treatment

HCC Risk Prediction Model - For Treatment-Naive Patients

Gender

Male Female

Age (years)

30-34 35-39

40-44 45-49

50-54 55-59

60-64

Alanine Aminotransferase (ALT, U/L)

<15 15-44

≥45

e Antigen (HBeAg)

Negative Positive

HBV DNA Load (copies/mL)

<300 300-999

10000-99999 100000-999999

≥100000

Note: This tool is applicable to treatment-naive hepatitis B patients with HBV DNA ≥ 20 IU/mL.

Due to the limitations of the data you provided, this test result is for reference only and does not represent any medical advice. Specific diagnosis and treatment should be based on the opinion of professional physicians.

References:

Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score

Favorite